{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:43:49Z","timestamp":1790984629534,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,15]]},"DOI":"10.1097\/tp.0b013e3181d9e1c0","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T08:12:22Z","timestamp":1269418342000},"page":"1385-1390","source":"Crossref","is-referenced-by-count":57,"title":["Effect of the Proteasome Inhibitor Bortezomib on Humoral Immunity in Two Presensitized Renal Transplant Candidates"],"prefix":"10.1097","volume":"89","author":[{"given":"Markus","family":"Wahrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Haidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther F.","family":"K\u00f6rm\u00f6czi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Weichhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus D.","family":"S\u00e4emann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Geyeregger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Kiki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Prikoszovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Drach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg A.","family":"B\u00f6hmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1034\/j.1600-6143.2003.00135.x","article-title":"Humoral theory of transplantation.","volume":"3","author":"Terasaki","year":"2003","journal-title":"Am J Transplant"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1600-6143.2007.01824.x","article-title":"Options for immunologic support of renal transplantation through the HLA and immunology laboratories.","volume":"7","author":"S\u00fcsal","year":"2007","journal-title":"Am J Transplant"},{"key":"R3-14-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000170864","article-title":"Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.","volume":"162","author":"Jordan","year":"2009","journal-title":"Contrib Nephrol"},{"key":"R4-14-20210129","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MOT.0b013e32832c433f","article-title":"Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization? We need both.","volume":"14","author":"Doxiadis","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-6143.2007.02039.x","article-title":"Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG.","volume":"8","author":"Perry","year":"2008","journal-title":"Am J Transplant"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production.","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1600-6143.2009.02612.x","article-title":"Mechanisms of alloantibody production in sensitized renal allograft recipients.","volume":"9","author":"Stegall","year":"2009","journal-title":"Am J Transplant"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.","volume":"352","author":"Richardson","year":"2005","journal-title":"N Engl J Med"},{"key":"R9-14-20210129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma.","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"key":"R10-14-20210129","first-page":"229","article-title":"Elimination of post-transplant donor-specific HLA antibodies with bortezomib.","author":"Idica","year":"2008","journal-title":"Clin Transpl"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MOT.0b013e328330f304","article-title":"Proteasome inhibition for antibody-mediated rejection.","volume":"14","author":"Everly","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"R13-14-20210129","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma.","volume":"348","author":"Richardson","year":"2003","journal-title":"N Engl J Med"},{"key":"R14-14-20210129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.TP.0000080685.31697.FC","article-title":"Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.","volume":"76","author":"Jordan","year":"2003","journal-title":"Transplantation"},{"key":"R15-14-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-6143.2006.01613.x","article-title":"Immunoadsorption in severe C4d-positive acute kidney allograft rejection: A randomized controlled trial.","volume":"7","author":"B\u00f6hmig","year":"2007","journal-title":"Am J Transplant"},{"key":"R16-14-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/TP.0b013e3181b04a5f","article-title":"Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program.","volume":"88","author":"Claas","year":"2009","journal-title":"Transplantation"},{"key":"R17-14-20210129","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/204998b0","article-title":"Microdroplet assay of human serum cytotoxins.","volume":"204","author":"Terasaki","year":"1964","journal-title":"Nature"},{"key":"R18-14-20210129","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1432-2277.2009.00912.x","article-title":"Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.","volume":"22","author":"Wahrmann","year":"2009","journal-title":"Transpl Int"},{"key":"R19-14-20210129","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/TP.0b013e3181a4b91b","article-title":"Abrogation of anti-HLA antibodies via proteasome inhibition.","volume":"87","author":"Trivedi","year":"2009","journal-title":"Transplantation"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/eji.200737743","article-title":"Dampening Ab responses using proteasome inhibitors following in vivo B cell activation.","volume":"38","author":"Cascio","year":"2008","journal-title":"Eur J Immunol"},{"key":"R21-14-20210129","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2005-05-2118","article-title":"Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines.","volume":"107","author":"Blanco","year":"2006","journal-title":"Blood"},{"key":"R22-14-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00007890-200107150-00016","article-title":"Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.","volume":"72","author":"Theruvath","year":"2001","journal-title":"Transplantation"},{"key":"R23-14-20210129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-0012.2005.00261.x","article-title":"Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.","volume":"19","author":"Lederer","year":"2005","journal-title":"Clin Transplant"},{"key":"R24-14-20210129","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1763","article-title":"The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.","volume":"14","author":"Neubert","year":"2008","journal-title":"Nat Med"},{"key":"R25-14-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2007.04.009","article-title":"New concepts of complement in allorecognition and graft rejection.","volume":"248","author":"Wasowska","year":"2007","journal-title":"Cell Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3181d9e1c0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:21:05Z","timestamp":1620976865000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201006150-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,15]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181d9e1c0","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6,15]]}}}